Announcements Trials

Browse Landscape

Phase

Status

Terminated 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Glioma 1 Communication Disorders 1

Interventions

pembrolizumab 28 Carboplatin 13 Nivolumab 12 Cisplatin 12 atezolizumab 10 Paclitaxel 10 venetoclax 9 Ipilimumab 9 Radiotherapy 8 Pemetrexed 8 Docetaxel 8 fludarabine 7 durvalumab 7 Specimen Handling 7 Gemcitabine 7 Cyclophosphamide 7 Bevacizumab 7 fludarabine phosphate 6 Practice Guidelines as Topic 6 Cetuximab 6 Biopsy 6 tislelizumab 5 enzalutamide 5 Trastuzumab 5 Standard of Care 5 Radiosurgery 5 Magnetic Resonance Spectroscopy 5 Dexamethasone 5 Cytarabine 5 tazemetostat 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Speech Therapy × 90 days × Clear all

NCT05189366 2026-04-14

SOPHNEURO

Institut Cancerologie de l'Ouest

Phase NA Terminated

13 enrolled 8 charts

Communication Disorders, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡